European Leukemia Trial Registry
Trial: SAMBA

More Details
Title JNJ-56022473 bei MDS und AML nach Versagen einer Therapie basierend auf hypomethylierenden Substanzen
Short Title SAMBA
Trialgroup Deutsche MDS
Type of Trial multicentric, single-group, open-label
Disease Myelodysplastic Syndrome(MDS) Low risk and intermedia I
Myelodysplastic Syndrome(MDS) Intermedia II and high risk
Myelodysplastic Syndrome(MDS) RAEB I
Myelodysplastic Syndrome(MDS) RAEB II
Age >= 18 years
Status Closed
Start of Recruitment 01.09.2016
Leader Platzbecker, Prof. Dr. med., Uwe
Contactperson

Administrative needs
Gloaguen, Silke
Tel: +49 (0)351 4584722
Email: silke.gloaguen@uniklinikum-dresden.de

Shortprotocol Shortprotocol
created 11.10.2016 Student Studienregister
changed 21.03.2018 Martina Wolkenfeld
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org